Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Xeris Biopharma Holdings, Inc. (XERS) had Current Ratio of 2.19 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$85.81M |
|
$11.08M |
|
$10.95M |
|
$74.86M |
|
$69.03M |
|
$16.77M |
|
$-5.69M |
|
$11.08M |
|
$11.08M |
|
$11.08M |
|
$11.08M |
|
$11.08M |
|
$11.08M |
|
$16.77M |
|
$20.84M |
|
160.43M |
|
172.74M |
|
$0.07 |
|
$0.07 |
|
| Balance Sheet Financials | |
$240.31M |
|
$4.95M |
|
$143.21M |
|
$383.53M |
|
$109.57M |
|
$220.34M |
|
$260.26M |
|
$369.84M |
|
$13.69M |
|
$-97.25M |
|
$13.69M |
|
166.22M |
|
| Cash Flow Statement Financials | |
$28.63M |
|
$-0.70M |
|
$11.39M |
|
$75.74M |
|
$115.06M |
|
$39.32M |
|
$22.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
2.19 |
-- |
|
-- |
|
0.94 |
|
16.10 |
|
87.24% |
|
19.55% |
|
19.55% |
|
-- |
|
12.91% |
|
12.91% |
|
$27.93M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
0.16 |
|
1.68 |
|
53.54 |
|
80.95% |
|
-11.39% |
|
2.89% |
|
4.74% |
|
$0.08 |
|
$0.16 |
|
$0.17 |
|